Effects of oral chlortetracycline and dietary protein level on plasma concentrations of growth hormone and thyroid hormones in beef steers before and after challenge with a combination of thyrotropin-releasing hormone and growth hormone-releasing hormone

被引:0
|
作者
Rumsey, TS
McLeod, K
Elsasser, TH
Kahl, S
Baldwin, RL
机构
[1] USDA ARS, Growth Biol Lab, Inst Livestock & Poultry Sci, Beltsville, MD 20705 USA
[2] USDA ARS, Nutrient Conservat & Metab Lab, Inst Livestock & Poultry Sci, Beltsville, MD 20705 USA
关键词
antibiotics; chlortetracycline; cattle; somatotropin; thyroxine; triiodothyronine;
D O I
暂无
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The objective of this study was to determine the effect of a subtherapeutic level of chlortetracycline (CTC) fed to growing beef steers under conditions of limited and adequate dietary protein on plasma concentrations of GH, thyroid-stimulating hormone (TSH), and thyroid hormones before and after, an injection of thyrotropin-releasing hormone (TRH) + GHRH. Young beef steers (n = 32 average BW = 285 kg) were assigned to a 2 x 2 factorial arrangement of treatments' of either a 10 or 13% crude protein diet (70% concentrate, 15% wheat straw, and 15% cottonseed hulls) and either a corn meal carrier or carrier + 350 mg of CTC daily top dressed on the diet. Steers were fed ad libitum amounts of diet for 56 d, and a jugular catheter was then placed in each steer in four groups (two steers from each treatment combination per group) during four consecutive days (one group per day). Each steer was injected via the jugular catheter with 1.0 mu g/kg BW TRH + .1 mu g/kg BW GHRH in 10 mt of saline at 0800. Blood samples were collected at -30, -15, 0, 5, 10, 15, 20, 30, 45, 60, 120, 240, and 360 min after releasing hormone injection. Plasma samples were analyzed for GH, TSH, thyroxine (T-4), and triiodothyronine (T-3). After 84 d on trial, the steers were slaughtered and the pituitary and samples of liver were collected and analyzed for 5'-deiodinase activity. Feeding CTC attenuated the GH response to releasing hormone challenge by 26% for both area under the response curve (P < .03) and peak response (P < .10). Likewise, CTC attenuated the TSH response to releasing hormone challenge for area under the response curve by 16% (P < .10) and peak response by 33% (P < .02), and attenuated the T-4 response for area under the curve by 12% (P < .08) and peak response by 14% (P < .04). Type II deiodinase activity in the pituitary was 36% less (P < .02) in CTC-fed steers than in Steers not fed CTC. The results of this study are interpreted to suggest that feeding subtherapeutic levels of CTC to young growing beef cattle attenuates the release of GH and TSH in response to pituitary releasing hormones, suggesting a mechanism by which CTC may influence tissue deposition in cattle.
引用
收藏
页码:2079 / 2087
页数:9
相关论文
共 50 条
  • [31] Thyroid function in early pregnancy II: Paradoxical growth hormone response to thyrotropin-releasing hormone
    De Leo, V
    la Marca, A
    Lanzetta, D
    Pasqui, L
    Morgante, G
    GYNECOLOGICAL ENDOCRINOLOGY, 1998, 12 (03) : 197 - 201
  • [32] EFFECTS OF GLUCOSE ON THYROTROPIN-RELEASING-HORMONE, GROWTH HORMONE-RELEASING HORMONE, SOMATOSTATIN AND LUTEINIZING-HORMONE-RELEASING HORMONE-RELEASE FROM RAT HYPOTHALAMUS INVITRO
    LEWIS, BM
    DIEGUEZ, C
    HAM, J
    PAGE, MD
    CREAGH, FM
    PETERS, JR
    SCANLON, MF
    JOURNAL OF NEUROENDOCRINOLOGY, 1989, 1 (06) : 437 - 441
  • [33] Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients
    Diez, JJ
    Iglesias, P
    Sastre, J
    Mendez, J
    Selgas, R
    GomezPan, A
    NEPHRON, 1996, 74 (03) : 548 - 554
  • [34] THE EFFECTS OF A GROWTH HORMONE-RELEASING PEPTIDE AND GROWTH HORMONE-RELEASING FACTOR IN CONSCIOUS AND ANESTHETIZED RATS
    CLARK, RG
    CARLSSON, LMS
    TROJNAR, J
    ROBINSON, ICAF
    JOURNAL OF NEUROENDOCRINOLOGY, 1989, 1 (04) : 249 - 255
  • [35] Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness
    Van den Berghe, G
    Wouters, P
    Weekers, F
    Mohan, S
    Baxter, RC
    Veldhuis, JD
    Bowers, CY
    Bouillon, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04): : 1311 - 1323
  • [36] Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer
    Ppulo, Helena
    Nunes, Bruno
    Sampaio, Cristina
    Batista, Rui
    Pinto, Marta Teixeira
    Gaspar, Tiago B.
    Miranda-Alves, Leandro
    Cai, Ren-Zhi
    Zhang, Xian Yang
    Schally, Andrew V.
    Sobrinho-Simes, Manuel
    Soares, Paula
    HORMONES & CANCER, 2017, 8 (5-6): : 314 - 324
  • [37] Effects of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogue in the growth hormone-releasing hormone knock out mouse
    Fintini, Danilo
    Alba, Maria
    Schally, Andrew V.
    Bowers, Cyril Y.
    Parlow, A. F.
    Salvatori, Roberto
    NEUROENDOCRINOLOGY, 2005, 82 (3-4) : 198 - 207
  • [38] Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer
    Helena Pópulo
    Bruno Nunes
    Cristina Sampaio
    Rui Batista
    Marta Teixeira Pinto
    Tiago B. Gaspar
    Leandro Miranda-Alves
    Ren-Zhi Cai
    Xian Yang Zhang
    Andrew V. Schally
    Manuel Sobrinho-Simões
    Paula Soares
    Hormones and Cancer, 2017, 8 : 314 - 324
  • [39] The effects of lithium therapy on thyroid and thyrotropin-releasing hormone
    Lazarus, JH
    THYROID, 1998, 8 (10) : 909 - 913
  • [40] Twenty-four hour rhythms of hypothalamic corticotropin-releasing hormone, thyrotropin-releasing hormone, growth hormone-releasing hormone and somatostatin in rats injected with Freund's adjuvant
    Esquifino, AI
    Selgas, L
    Vara, E
    Arce, A
    Cardinali, DP
    BIOLOGICAL SIGNALS AND RECEPTORS, 1999, 8 (03): : 178 - 190